{"id":432567,"date":"2021-02-10T06:21:08","date_gmt":"2021-02-10T11:21:08","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=432567"},"modified":"2021-02-10T06:21:08","modified_gmt":"2021-02-10T11:21:08","slug":"tauriga-sciences-inc-commences-the-largest-tauri-gum-production-run-in-company-history-in-response-to-substantially-improved-macro-industry-outlook","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tauriga-sciences-inc-commences-the-largest-tauri-gum-production-run-in-company-history-in-response-to-substantially-improved-macro-industry-outlook\/","title":{"rendered":"Tauriga Sciences Inc. Commences the Largest Tauri-Gum Production Run in Company History in Response to Substantially Improved Macro-Industry Outlook"},"content":{"rendered":"
\n

The Tauri-Gum\u2122 Product Line has Increased its Cannabidiol (\u201cCBD\u201d) and Cannabigerol (\u201cCBG\u201d) Infusion Concentrations to 20mg per Each Piece of Chewing Gum<\/p>\n

NEW YORK, NY, Feb. 10, 2021 (GLOBE NEWSWIRE) — via NewMediaWire<\/u><\/a> — Tauriga Sciences, Inc. (OTCQB:\u00a0TAUG) (\u201cTauriga\u201d or the \u201cCompany\u201d), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, today announced that it has commenced the largest Tauri-Gum\u2122 production run in Company history, in response to substantially improved macro-industry outlook.\u00a0 Additionally, the Company continues to experience increasingly strong levels of interest \u2013 from a broad array of prospective retail & wholesale customers.\u00a0 \u00a0When completed, this above-referenced production run will yield Tauri-Gum\u2122 product inventory \u2013 worth in terms of retail value \u2013 well in excess of $1,000,000 USD.<\/p>\n

There has also been an important formulation modification, applicable to this production run.\u00a0 The Company has made the strategic decision to increase the CBD and CBG infusion concentrations to 20mg per each piece of chewing gum.\u00a0 Accordingly \u2013 Mint, Blood Orange, Pomegranate Tauri-Gum\u2122 flavors (20mg CBD \/ each piece of chewing gum) and Peach-Lemon, Black Currant Tauri-Gum\u2122 flavors (20mg CBG \/ each piece of chewing gum).\u00a0 The Packaging will also be updated to reflect all of the certifications (i.e. Kosher, Halal) and compliance features (i.e. QR codes, UPCs).<\/p>\n

Moving forward, the Company is confident about its growth prospects for the remainder of Calendar Year 2021.\u00a0 The Company\u2019s highest margin E-Commerce business segment continues to show overall strength and there has been an acceleration in online customer acquisition.\u00a0 Lastly, the Company has worked with great diligence to enhance its existing infrastructure and increase its production capacity \u2013 to strengthen its ability to meet potential increases in demand.<\/p>\n

\n ABOUT TAURIGA SCIENCES INC.<\/strong>\n <\/p>\n

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.\u00a0\u00a0The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (\u201cCBD\u201d) and Cannabigerol (\u201cCBG\u201d) Edibles market segment.\u00a0\u00a0The main product line, branded as Tauri-Gum\u2122, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum\u2122 Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum\u2122 Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc \u201cImmune Booster\u201d Flavor: Pear Bellini).\u00a0\u00a0The Company\u2019s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website:\u00a0www.taurigum.com<\/u><\/a>). Please visit our corporate website, for additional information, as well as inquiries, at\u00a0http:\/\/www.tauriga.com<\/p>\n

Complementary to the Company\u2019s retail business, is its ongoing Pharmaceutical Development initiative.\u00a0 This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum\u2122, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 18, 2020, the Company announced that it had filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum\u2122.\u00a0 The Patent, filed with the U.S.P.T.O. is Titled \u201cMEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT\u201d.\u00a0 On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company’s clinical development efforts.<\/p>\n

On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4).<\/p>\n

The Company is headquartered in Wappingers Falls, New York.\u00a0\u00a0In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.<\/p>\n

\n DISCLAIMER — Forward-Looking Statements<\/strong>\n <\/p>\n

This press release contains certain \u201cforward-looking statements\u201d as defined by the Private Securities Litigation Reform Act of 1995 which represent management\u2019s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as \u201cmay,\u201d \u201cwill,\u201d \u201cexpects,\u201d \u201canticipates,\u201d believes, \u201chopes,\u201d \u201cbelieves,\u201d or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management\u2019s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in\u00a0 forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the \u201cRisk Factors\u201d section of Tauriga\u2019s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.<\/p>\n

\n Contact:<\/strong>\n <\/p>\n

Tauriga Sciences, Inc.
4 Nancy Court, Suite 4
Wappingers Falls, NY 12590
Chief Executive Officer
Mr. Seth M. Shaw
Email:\u00a0 sshaw@tauriga.com
cell # (917) 796 9926
Company Instagram: @taurigum
Personal Instagram:\u00a0 @sethsms47
Twitter: @SethMShaw
Corp. Website:\u00a0\u00a0 www.tauriga.com<\/u><\/a>
E-Commerce Website:\u00a0 www.taurigum.com<\/a><\/u><\/p>\n

\n Attachment<\/strong>\n <\/p>\n